Sertoli-Leydig Cell Tumor from Latifa Hospital, Dubai UAE: Case Report

HTML  XML Download Download as PDF (Size: 467KB)  PP. 319-325  
DOI: 10.4236/ojog.2020.1020028    525 Downloads   1,340 Views  

ABSTRACT

Sertoli-Leydig cell tumors (SLCTs) are rare tumors. Mass and pain are the presenting feature. The varying histopathology and differentiation of this tumor present difficulties with proper diagnosis and development of optimal treatment regimens. The prognosis depends on tumors grading and staging. Surgery is main stay management option. Chemotherapy and radiation options are still of choice. We aimed to present Sertoli-Leydig cell tumor managed surgical at Latifa Hospital in Dubai, UAE with acceptable outcome and good patient satisfaction.

Share and Cite:

Almahloul, Z. , Fazari, A. , Paulose, L. , Nagshabandi, Z. and Gergawi, T. (2020) Sertoli-Leydig Cell Tumor from Latifa Hospital, Dubai UAE: Case Report. Open Journal of Obstetrics and Gynecology, 10, 319-325. doi: 10.4236/ojog.2020.1020028.
Journals Menu
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.